Coronavirus (COVID-19)
Learn more
July 31, 2020
Unlike many other activities, cancer care has continued during the COVID-19 pandemic. At the Hartford HealthCare Cancer Institute, patients are seeking diagnosis and treatment for various types of cancers throughout the pandemic. That is why it’s important to push ahead with fundraising efforts to help them. “To say that things…
Editor’s note: This recently ran as an op-ed in The Hartford Courant. By Drs. Peter P. Yu and Andrew L. Salner The coronavirus pandemic has upended every component of our lives, but it is having a particularly profound effect on how hospitals treat cancer patients. We are recalibrating quickly, but…
July 29, 2020
All this time we’ve spent thinking of ways to avoid cancer and an answer is sitting in front of us every morning in our steaming cup of coffee. The American Cancer Society, in a new level of definitiveness when it updated guidelines last month for diet and physical activity for…
By Dr. Charles E. Rutter Radiation Oncologist Hartford HealthCare Cancer Institute Hartford Hospital Cancer therapy continues to evolve and advance over time, with immunotherapy, molecularly targeted drugs and new generations of hormone-mediated treatments leading to improvements in survival and quality of life. Despite these improvements, roughly 30 percent of patients…
July 28, 2020
July 15, 2020
The Hospital of Central Connecticut in New Britain is now using a new endoscopic technology known as the Monarch Platform, developed by Auris Health, that holds promise for earlier and more accurate diagnosis in patients at risk for lung cancer. The Monarch Platform has been cleared by the Food and…
July 07, 2020
The Hartford HealthCare Cancer Institute announces the hiring of hematologist/oncologist Dr. Pallvi Popli, who begins seeing patients in facilities in Hartford and Willimantic this month. Dr. Popli comes to Hartford HealthCare from fellowship training at the Robert Wood Johnson Medical School at Rutgers University, where her focus was on hematology…
July 06, 2020
In an attempt to help people who struggle daily with chronic pain, a state regulatory committee recently added it as a qualifying condition for medical marijuana. “A lot of people live with pain,” said Dr. Andrew Salner, director of the Hartford HealthCare Cancer Institute at Hartford Hospital and a member of…
June 08, 2020
Dr. Brian Byrne Medical Oncologist Hartford HealthCare Cancer Institute There are two big events in June that always remind me of why I chose to become an oncologist. The first is the annual ASCO (American Society of Clinical Oncology) meeting that usually takes place in Chicago, but this year was…
By Gretchin Bade Oncology Program Lead Hartford Hospital Rehabilitation Network Joint pain, also known as arthralgias, occurs in 50 percent of breast cancer survivors treated with aromatase inhibitors. Research has found that exercise decreases the joint pain which can be a side effect of the aromatase inhibitors, a type of…
Get the latest healthcare news directly in your inbox.